Stockreport

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF in (preload) venous blood return to the heart and a decrease in (afterload) due to arterial dilatation India is the first global territory where Centhaquine is being l [Read more]